Open Access 05.12.2018 | Correction
Correction to: Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons
Erschienen in: Diabetes Therapy | Ausgabe 1/2019